ART First-line Treatment Durability in Russia

NCT04253119 · clinicaltrials.gov ↗

COMPLETED

Status

536

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Antiretroviral/Anti HIV

Sponsor

MSD Pharmaceuticals LLC